As of 05/19/2025, Conduit Pharmaceuticals's market capitalization has reached $4.66 M. According to our data, Conduit Pharmaceuticals is the 42893th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Conduit Pharmaceuticals has seen its market value drop from $177.17 M to $4.66 M since 2022, representing a total decrease of 97.37% and an annual compound decline rate (CAGR) of 78.22%.
Date
Market Cap
Change (%)
05/19/2025
$4.66 M
-44.84%
12/31/2024
$8.22 M
-97.52%
12/29/2023
$331.30 M
86.99%
12/30/2022
$177.17 M
Company Profile
Conduit Pharmaceuticals was founded in 2019 in United States.
on the Nasdaq Stock Market.
With 6 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
As of 05/19/2025, Conduit Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $4.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Conduit Pharmaceuticals global market capitalization ranking is approximately 42893 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.